Does continuation of antifibrotics before lung transplantation influence post-transplant outcomes in patients with idiopathic pulmonary fibrosis?

A best evidence topic was written according to a structured protocol. The question addressed was: ‘Does continuation of antifibrotics before lung transplantation (LTx) influence post-transplant outcomes in patients with idiopathic pulmonary fibrosis (IPF) with regard to mortality, bronchial anastomo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Michael Z L, Huang, Joanna Yilin, Liu, David Hongwei, Snell, Gregory I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Thoracic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766206/
https://www.ncbi.nlm.nih.gov/pubmed/34453531
http://dx.doi.org/10.1093/icvts/ivab237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766206/
https://www.ncbi.nlm.nih.gov/pubmed/34453531
http://dx.doi.org/10.1093/icvts/ivab237

Ejemplares similares